ACTRN12613001128785已完成1 期
A single dose, randomized, blinded, pilot bioequivalence study of metoprolol tablets in a 2 way crossover comparison against the innovator metoprolol tablet conducted under fasting conditions in healthy male and female volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Healthy males and non-pregnant females
- •Aged between 18 and 55
- •Non-smoker
- •BMI between 19 and 30
- •Normal, healthy individuals as determined by medical history, physical examination, ECG, bood pressure and laboratory tests
- •Able to provide written informed consent
排除标准
- •Any history of recent recurrent attacks of bronchitis, asthma, migraine headaches
- •Concomitant drug therapy of any kind excluding prescribed hormonal contraceptives
- •Who have a history chest complaints, heart conditions or a very slow heart beats or uneven heart beat
- •Sensitivity to metoprolol, any beta-blocker medicines, excipients of metoprolol
- •History of any conditions that might interfere with the absorption, distribution, metabolism or excretion of the drug
- •Females who are breastfeeding or are planning to start a family within 60 days of dosing
- •Smoker (anyone who has smoked in the last 6 months)
- •History of alcohol or drug abuse or dependency
- •Participation in a drug study within 60 days of the start of the study or donated blood in the 60 days preceding the study.
- •Volunteers for whom the Clinical Investigator believes, for any reason, that participation would not be an acceptable risk.
研究者
相似试验
已完成
1 期
A single dose, randomized, blinded, pilot, comparative assessment of the absorption of a generic formulation of tibolone tablet against the innovator tibolone tablet conducted in healthy female volunteers under fasting conditionsACTRN12613000943741Zenith Technology Corporation Limited8
已完成
1 期
Comparative assessment of the absorption of 3 generic formulations of isotretinoin capsules against the innovator isotretinoin capsule in a pilot study conducted under fasting conditions in healthy male volunteersACTRN12615000569505Zenith Technology Corp Ltd16
已完成
1 期
Comparative assessment of the absorption of an Iron Polymaltose tablet against an innovator product conducted in iron deficient participants under fed conditions with diet control (low iron and low fat).Iron DificiencyDiet and Nutrition - Other diet and nutrition disordersBlood - AnaemiaACTRN12623001001684Zenith Technology Corporation Limited24
已完成
1 期
Comparative assessment of the absorption of a generic formulation of Iron Polymaltose tablet against the innovator Maltofer tablet conducted in iron deficient participants under fed conditions with diet control.Iron DificiencyBlood - AnaemiaDiet and Nutrition - Other diet and nutrition disordersACTRN12623000530628Zenith Technology Corporation Limited12
已完成
1 期
Comparative assessment of the absorption of a generic formulation of clobazam tablet against the innovator clobazam tablet conducted under fasting conditions in healthy male and female volunteersACTRN12616000117415Zenith Technology Corp Ltd33